News for Edwards Lifesciences Corporation (E1WL34.SA)

PR NewswireGALWAY, Ireland and WASHINGTON, March 9, 2025 CRT 2025 Late Breaking Science features largest head-to-head randomized control TAVR trial to prim

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen 45th Annual Health Care Conference on Tuesday, Mar. 4, 2025.

Edwards Lifesciences Corporation (NYSE:EW) Q4 2024 Earnings Conference Call February 11, 2025 5:00 PM ETCompany ParticipantsMark Wilterding - Senior Vice...

Stock Market today | Share Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 4 February 2025.

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.

Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025. Bernard Z

Grabar Law Office Investigates Claims on Behalf of Shareholders of Edwards Lifesciences Corporation (EW)

We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against...

We recently compiled a list of the 7 Stocks that Jim Cramer Recently Discussed.

NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Edwards Lifesciences

[url="]The Law Offices of Frank R. Cruz[/url] reminds investors of the upcoming December 13, 2024 deadline to file a lead plaintiff motion in the class action

Class A shares underperformed the MSCI All-Country World Growth Index and the Morningstar Global Large Stock Growth Category average (5.10% return) during the third quarter.

The Intensive Care Unit Equipment Market Size sector reached a market value of USD 6.84 Billion in 2022. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 3.9%…

The global medical devices market is poised for significant growth, expanding from USD 481.92 billion in 2023 to USD 756.59 billion by 2031, at a CAGR of...

In Q3 2024, Baron Health Care Fund advanced 5.81% (Inst), vs. 6.74% gain for the Russell 3000 Health Care Index (Benchmark). Click here to read the full letter.

As per Fortune Business Insights’ report, the intensive care unit equipment Market share sector attained a worth of USD 6.84 Billion in 2022. Forecasts indicate a promising path, foreseeing a…

Hemodynamic monitoring devices industry is projected to witness a CAGR of 5.9% during the period 2024-2032. This growth can be attributed to growing...